All lobbying filings

Fierce Government Relations

Fierce Government Relations filed a Q1 report for Association of Accessible Medicines (Formerly Known as Gpha) on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Association of Accessible Medicines (Formerly Known as Gpha) · Trade Organization for Generic Drug Manufacturers and Distributers

As filed: FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA).

All filings by Fierce Government Relations · Everything Association of Accessible Medicines (Formerly Known as Gpha) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Supply Chain; Drug Shortages; Generic Drugs; S.1414 - Expedited Access to Biosimilars Act; S.1954 - Biosimilar Red Tape Reduction Act; S.3788 - Clear Labels Act;S.3510 - Biosimilar Inspection Modernization Act; API; Issues around Country of Origin labeling.

Bills named in this filing 4

S. 1414
Expedited Access to Biosimilars Act
S. 1954
Biosimilar Red Tape Elimination Act
S. 3788
CLEAR LABELS Act
S. 3510
Biosimilar Inspection Modernization Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.